These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28142291)

  • 21. Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.
    Tang C; Godfrey T; Stawell R; Nikpour M
    Intern Med J; 2012 Sep; 42(9):968-78. PubMed ID: 22827853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
    Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
    Kreuter A; Gaifullina R; Tigges C; Kirschke J; Altmeyer P; Gambichler T
    Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort.
    Molad Y; Gorshtein A; Wysenbeek AJ; Guedj D; Majadla R; Weinberger A; Amit-Vazina M
    Lupus; 2002; 11(6):356-61. PubMed ID: 12139373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
    Hu C; Lu L; Wan JP; Wen C
    Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Lupus Erythematosus and Pregnancy.
    Lateef A; Petri M
    Rheum Dis Clin North Am; 2017 May; 43(2):215-226. PubMed ID: 28390564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus.
    Jung H; Bobba R; Su J; Shariati-Sarabi Z; Gladman DD; Urowitz M; Lou W; Fortin PR
    Arthritis Rheum; 2010 Mar; 62(3):863-8. PubMed ID: 20131232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of smoking on the effectiveness of antimalarial drugs for cutaneous lesions of patients with lupus: assessment in a prospective study].
    Lardet D; Martin S; Truchetet F; Cuny JF; Virion JM; Schmutz JL
    Rev Med Interne; 2004 Nov; 25(11):786-91. PubMed ID: 15501347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimalarials--the 'real' advance in lupus.
    Wallace DJ
    Lupus; 2001; 10(6):385-7. PubMed ID: 11434570
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimalarial therapy in SLE.
    Lanham JG; Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract]   [Full Text] [Related]  

  • 31. A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.
    Costedoat-Chalumeau N; Dunogué B; Leroux G; Morel N; Jallouli M; Le Guern V; Piette JC; Brézin AP; Melles RB; Marmor MF
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):317-26. PubMed ID: 25672591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Disseminated lupus erythematosus. The continued efficacy of hydroxychloroquine scientifically proven by default].
    Carette S
    Union Med Can; 1991; 120(5):360-4. PubMed ID: 1962386
    [No Abstract]   [Full Text] [Related]  

  • 33. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs.
    Rahman P; Gladman DD; Urowitz MB; Yuen K; Hallett D; Bruce IN
    J Rheumatol; 1999 Feb; 26(2):325-30. PubMed ID: 9972966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombovascular events in systemic lupus erythematosus: comment on the article by Jung et al.
    Wallace DJ
    Arthritis Rheum; 2010 Sep; 62(9):2824; author reply 2824-5. PubMed ID: 20872599
    [No Abstract]   [Full Text] [Related]  

  • 36. [The safety of hydroxychloroquine in pregnant patients with systemic lupus erythematosus].
    Zhang L; Ma L; Lin B; Wu DH; Wang GC
    Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):918-21. PubMed ID: 22333122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxychloroquine: past, present, future.
    Petri M
    Lupus; 1998; 7(2):65-7. PubMed ID: 9541087
    [No Abstract]   [Full Text] [Related]  

  • 38. The efficacy of antimalarials in systemic lupus erythematosus.
    Esdaile JM
    Lupus; 1993 Feb; 2 Suppl 1():S3-8. PubMed ID: 8485568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimalarial therapy: a panacea for mild lupus?
    D'Cruz D
    Lupus; 2001; 10(3):148-51. PubMed ID: 11315343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practice Gaps. Optimizing antimalarial therapy for cutaneous lupus erythematosus: comment on "Response to antimalarial agents in cutaneous lupus erythematosus".
    Callen JP
    Arch Dermatol; 2011 Nov; 147(11):1267-8. PubMed ID: 22106112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.